MARKET

GNPX

GNPX

Genprex Inc
NASDAQ
1.310
-0.060
-4.38%
After Hours: 1.310 0 0.00% 16:19 04/08 EDT
OPEN
1.390
PREV CLOSE
1.370
HIGH
1.440
LOW
1.260
VOLUME
634.86K
TURNOVER
--
52 WEEK HIGH
55.00
52 WEEK LOW
1.260
MARKET CAP
11.85M
P/E (TTM)
-0.0753
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GNPX last week (0330-0403)?
Weekly Report · 2d ago
Genprex FY25 net loss narrows 23% to $16M
Reuters · 03/30 21:42
Weekly Report: what happened at GNPX last week (0323-0327)?
Weekly Report · 03/30 10:17
Top Ranking Stock Picker From Congress Is Back Buying Small Cap Stocks Again: Here Are The Tickers
Benzinga · 03/27 17:10
Weekly Report: what happened at GNPX last week (0316-0320)?
Weekly Report · 03/23 10:14
Genprex Highlights New Reqorsa Preclinical Data at AACR
TipRanks · 03/18 12:35
Genprex collaborators present on use of Reqorsa at AACR meeting
TipRanks · 03/18 11:11
Genprex collaborators to present Reqorsa lung cancer preclinical data at AACR annual meeting
Reuters · 03/18 11:05
More
About GNPX
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Company's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which uses lipid-based nanoparticles in a lipoplex form to deliver tumor suppressor gene-expressing plasmids to cancer cells. Its oncology drug candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is developed in combination with approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). GPX-002 is being developed by the Company using the same construct for the treatment of both Type 1 diabetes and Type 2 diabetes. GPX-002 for Type 1 diabetes is designed to work by transforming alpha cells in the pancreas into functional beta-like cells.

Webull offers Genprex Inc stock information, including NASDAQ: GNPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNPX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNPX stock methods without spending real money on the virtual paper trading platform.